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doi:10.1016/j.ejvsextra.2011.06.008Abstract Introduction: Hemodialysis Reliable Outflow (HeRO) (Hemosphere Inc, Minneapolis,
MN, USA) vascular access device is a new long-term subcutaneous access designed for patients
who have exhausted traditional peripheral access sites.
Report: We describe the use of the HeRO device not to create new access but to resolve symp-
toms of venous hypertension and salvage still functional arteriovenous fistula (AVF) in a patient
refractory to endovascular treatment of recurrent central venous occlusive disease (CVOD).
Conclusion: This report reinforces the experience of other authors that the HeRO device is an
effective means to salvage an AV access and relieve symptoms of venous hypertension.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.Central venous occlusive disease (CVOD) is a complication
that coupled with the high flow of an arteriovenous fistula
(AVF) may cause severe venous hypertension, compromising
access functionality.1 Current management includes
percutaneous angioplasty and stenting, but this often
requires repeat interventions.1 Surgical bypass may provide
a longer-term solution, but it is a more invasive approach
not without its own complications.2jvs.2011.06.055.
3 441 5200; fax:þ1 713 441
g (E.K. Peden).
r Vascular Surgery. Published byThe Hemodialysis Reliable Outflow (HeRO) vascular access
device is a new, long-term access ideal for patients with
exhausted traditional peripheral access sites.3 We describe
its use not to create new access but to resolve symptoms of
venous hypertension and salvage a functional AVF.Case Report
A 53-year-old woman with a right brachiocephalic fistula
became complicated by CVOD refractory to repeated
endovascular treatment. She first presented with right arm
swelling 1 month after the fistula creation, during which
time she was relying on a tunnelled dialysis catheter (TDC)Elsevier Ltd. Open access under CC BY-NC-ND license.
Figure 1 Contrast venography demonstrating the tight stenosis in the junction of the right subclavian and brachiocephalic veins
(black arrow) (A) the extent of multiple stents (Between white arrows) can be observed in the preoperative Chest X ray (B). The
outflow component of the HeRO device (white arrow) was positioned over the wire with its tip in the right atrium (C), and then
connected to the graft component of the device. The graft (between the two black arrows not observed in this fluoroscopic study)
was then tunnelled down and connected to the cephalic vein via end-to-end anastomosis (D).
Figure 2 Diagram illustrates the use of the HeRO device in
this particular case. The outflow component crosses a long
venous segment from cephalic vein to the right atrium; the
hollow arrow indicates the venotomy site, the previously
stented portion is located between the black arrows. Subse-
quently the graft component is connected to the cephalic vein
in end-to-end fashion.
e38 G.J. Chen et al.in her right internal jugular vein (IJ) for access while
awaiting fistula maturation. Venography demonstrated
right brachiocephalic vein occlusion at the site of the IJ
catheter. Balloon dilatation of right brachiocephalic vein
was performed with improvement in flow. Over the next 2
years, she experienced recurrent symptoms due to lesions
in the right subclavian and brachiocephalic veins. She
endured four additional angioplasties, one bare metal and
one covered stent placement, as well as thrombectomy of
the stent-graft outflow itself. The contralateral arm
demonstrated poor veins on vessel mapping and CVOD by
venography.
The HeRO device was chosen for access salvage and to
relieve symptoms of venous hypertension. Venography
demonstrated the stenosis at the junction of the right
subclavian and brachiocephalic veins. The fistula was
punctured near the shoulder, and a wire was passed
through the stenosis into the inferior vena cava; a short
tunnel was then made between an incision in the upper arm
and an incision at the puncture site. After heparinisation,
the fistula was clamped near the upper-arm incision, and
sequential dilators were passed over the wire with fluoro-
scopic guidance. The outflow component of the HeRO
device was positioned through the stented vein segment
HeRO Device to Salvage a Functional Arteriovenous Fistula e39and then connected to the graft component of the device.
The graft was then tunnelled down and connected to the
cephalic vein via end-to-end anastomosis (Fig. 1(A)e(D)).
The clamps were then released, and flow re-established
with successful bypass of the venous occlusion. The arm
swelling resolved and the fistula could be used immediately
after the procedure and at 6 months remains fully func-
tional and no re-interventions have been required.
Discussion
Initial studies with the HeRO device have demonstrated
significantly lower rates of bacteraemia compared with TDC
and similar patency compared with traditional AV grafts.3,4
It is becoming an important option for patients who
otherwise have to rely on TDC. We, along with other early
report,5 have shown that this device can be used to salvage
an existing access in patients with symptomatic venous
hypertension refractory to multiple endovascular inter-
ventions. Instead of creating new access via anastomosis to
the brachial artery, the HeRO graft was connected to the
cephalic vein in an end-to-end fashion, and the outflow
component was used to cross the obstruction and provide
direct outflow into the right atrium (Fig. 2). It offers yet
another surgical option for the treatment of venous
hypertension secondary to CVOD. It promptly relieves the
associated morbid limb oedema and also allows for imme-
diate cannulation of the failing fistula, negating the need
for a bridging TDC.
The HeRO device offers a unique solution to patients
with failing AVF secondary to CVOD, using their existingaccess and eliminating the need for more complex
surgical solutions. Further studies will be needed to
compare the efficacy of this device with current access-
salvage options.Conflict of Interest/Funding
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